Benign and Malignant Neoplasms of the Exocrine Pancreas



Pancreatic neoplasms represent a major health-care problem for the aging population. The elderly are at risk for the entire spectrum of benign and malignant pancreatic tumors. Pancreatic adenocarcinoma is the most frequent and clinically significant of these tumors. It is the fourth leading cause of cancer death in the United States, and its incidence is associated with advancing age. The diagnosis and treatment of pancreatic cancer often represents a significant clinical challenge in the elderly, as there is a significant bias against aggressive surgical treatment in this population. In recent years, however, advances in diagnostic techniques, improved outcomes with regionalization of care, and a deeper understanding of prognostic factors have improved our ability to treat this challenging disease. In addition to pancreatic adenocarcinoma, the recognition and diagnosis of benign and premalignant pancreatic tumors has become more common in the elderly. These tumors require a thorough understanding of their clinical behavior as one weighs these risks with the risk of surgery in the elderly population. Fortunately, many of these tumors are amenable to less invasive therapeutic procedures with lessened perioperative morbidity and mortality.


Pancreatic Cancer Pancreatic Adenocarcinoma Obstructive Jaundice Pancreatic Resection Cystic Neoplasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Ries LM, D; Krapcho, M; Stinchcomb, DG; Howlader, N; Homer, MJ; Mariotto, A; Miller, BA; Fuer, EJ; Altekruse, SF; Lewis, DR; Clegg, L; Eisner, MP; Reichman, M; Edwards, BK (eds) (2007) SEER Cancer Stat Fact Sheets – Cancer of the Pancreas. Accessed 29 November 2008.
  2. 2.
    Salvia R, Fernandez-del Castillo C, Bassi C et al (2004) Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239(5):678–685PubMedCrossRefGoogle Scholar
  3. 3.
    Genkinger JM, Spiegelman D, Anderson KE, Bergkvist L, Bernstein L, van den Brandt PA (2009) Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev 18(3):765–776PubMedCrossRefGoogle Scholar
  4. 4.
    Klein AP, Brune KA, Petersen GM et al (2004) Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64(7):2634–2638PubMedCrossRefGoogle Scholar
  5. 5.
    Katz MH, Hwang R, Fleming JB et al (2008) Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin 58(2):111–125PubMedCrossRefGoogle Scholar
  6. 6.
    Katz MH, Mortenson MM, Wang H et al (2008) Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. J Am Coll Surg 207(1):106–120PubMedCrossRefGoogle Scholar
  7. 7.
    Tanaka M, Tanaka M (2004) Intraductal papillary mucinous neoplasm of the pancreas: diagnosis and treatment. Pancreas 28(3):282–288PubMedCrossRefGoogle Scholar
  8. 8.
    Hruban RH, Takaori K, Klimstra DS et al (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28(8):977–987PubMedCrossRefGoogle Scholar
  9. 9.
    Takaori K, Hruban RH, Maitra A, Tanigawa N (2004) Pancreatic intraepithelial neoplasia. Pancreas 28(3):257–262PubMedCrossRefGoogle Scholar
  10. 10.
    Sohn TA, Yeo CJ, Cameron JL et al (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239(6):788–797, discussion 797–789PubMedCrossRefGoogle Scholar
  11. 11.
    Brugge WR, Lewandrowski K, Lee-Lewandrowski E et al (2004) Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 126(5):1330–1336PubMedCrossRefGoogle Scholar
  12. 12.
    Winter JM, Cameron JL, Lillemoe KD et al (2006) Periampullary and pancreatic incidentaloma: A single institution's experience with an increasingly common diagnosis. Ann Surg 243(5):673–683PubMedCrossRefGoogle Scholar
  13. 13.
    Spencer MP, Sarr MG, Nagorney DM (1990) Radical pancreatectomy for pancreatic cancer in the elderly. Is it safe and justified? Ann Surg 212(2):140–143PubMedCrossRefGoogle Scholar
  14. 14.
    Richter A, Niedergethmann M, Lorenz D et al (2002) Resection for cancers of the pancreatic head in patients aged 70 years or over. Eur J Surg 168(6):339–344PubMedCrossRefGoogle Scholar
  15. 15.
    Kau SY, Shyr YM, Su CH, Wu CW, Lui WY (1999) Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers. J Am Coll Surg 188(4):415–420PubMedCrossRefGoogle Scholar
  16. 16.
    Nichols MT, Russ PD, Chen YK, Nichols MT, Russ PD, Chen YK (2006) Pancreatic imaging: current and emerging technologies. Pancreas 33(3):211–220PubMedCrossRefGoogle Scholar
  17. 17.
    Sahani DV, Shah ZK, Catalano OA et al (2008) Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 23(1):23–33PubMedCrossRefGoogle Scholar
  18. 18.
    Itoh S, Ikeda M, Satake H et al (2006) The effect of patient age on contrast enhancement during CT of the pancreatobiliary region. AJR Am J Roentgenol 187(2):505–510PubMedCrossRefGoogle Scholar
  19. 19.
    Friess H, Erkan M, Kleef J, Haberkorn U, Buchler MW (2008) Role of positron emission tomography in diagnosis of pancreatic cancer and cancer recurrence. In: Beger HG, Warshaw A, Buchler M, Kozarek R, Lerch M, Neoptolemos J, Shiratori K, Whitcomb D (eds) The pancreas: an integrated textbook of basic science, medicine, and surgery. Blackwell, Oxford, pp 648–655Google Scholar
  20. 20.
    Fogel EL, deBellis M, McHenry L et al (2006) Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study. Gastrointest Endosc 63(1):71–77PubMedCrossRefGoogle Scholar
  21. 21.
    Brugge WR (2006) Advances in the endoscopic management of patients with pancreatic and biliary malignancies. South Med J 99(12):1358–1366PubMedCrossRefGoogle Scholar
  22. 22.
    Fritz E, Kirchgatterer A, Hubner D et al (2006) ERCP is safe and effective in patients 80 years of age and older compared with younger patients. Gastrointest Endosc 64(6):899–905PubMedCrossRefGoogle Scholar
  23. 23.
    Rodriguez-Gonzalez FJ, Naranjo-Rodriguez A, Mata-Tapia I et al (2003) ERCP in patients 90 years of age and older. Gastrointest Endosc 58(2):220–225PubMedCrossRefGoogle Scholar
  24. 24.
    DeWitt J, Devereaux B, Chriswell M et al (2004) Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 141(10):753–763PubMedGoogle Scholar
  25. 25.
    Rafique A, Freeman S, Carroll N (2007) A clinical algorithm for the assessment of pancreatic lesions: utilization of 16- and 64-section multidetector CT and endoscopic ultrasound. Clin Radiol 62(12):1142–1153PubMedCrossRefGoogle Scholar
  26. 26.
    Agarwal B, Krishna NB, Labundy JL et al (2008) EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct. Gastrointest Endos 68(2):237–242, quiz 334CrossRefGoogle Scholar
  27. 27.
    Tamm EP, Loyer EM, Faria SC et al (2007) Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom Imaging 32(5):660–667PubMedCrossRefGoogle Scholar
  28. 28.
    Lall CG, Howard TJ, Skandarajah A et al (2007) New concepts in staging and treatment of locally advanced pancreatic head cancer. AJR Am J Roentgenol 189(5):1044–1050PubMedCrossRefGoogle Scholar
  29. 29.
    Dewitt J, Devereaux BM, Lehman GA et al (2006) Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol 4(6):717–725, quiz 664PubMedCrossRefGoogle Scholar
  30. 30.
    Clarke DL, Thomson SR, Madiba TE et al (2003) Preoperative imaging of pancreatic cancer: a management-oriented approach. J Am Coll Surg 196(1):119–129PubMedCrossRefGoogle Scholar
  31. 31.
    Barreiro CJ, Lillemoe KD, Koniaris LG et al (2002) Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit? J Gastrointest Surg 6(1):75–81PubMedCrossRefGoogle Scholar
  32. 32.
    Pisters PW, Lee JE, Vauthey JN, Charnsangavej C, Evans DB (2001) Laparoscopy in the staging of pancreatic cancer. Br J Surg 88(3):325–337PubMedCrossRefGoogle Scholar
  33. 33.
    Stefanidis D, Grove KD, Schwesinger WH, Thomas CR Jr (2006) The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review. Ann Oncol 17(2):189–199PubMedCrossRefGoogle Scholar
  34. 34.
    Kilic M, Gocmen E, Tez M et al (2006) Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer. Can J Surg 49(4):241–244PubMedGoogle Scholar
  35. 35.
    Howard L, Ashley C, Howard L, Ashley C (2003) Nutrition in the perioperative patient. Annu Rev Nutr 23:263–282PubMedCrossRefGoogle Scholar
  36. 36.
    Goonetilleke KS, Siriwardena AK, Goonetilleke KS, Siriwardena AK (2006) Systematic review of peri-operative nutritional supplementation in patients undergoing pancreaticoduodenectomy. JOP 7(1):5–13PubMedGoogle Scholar
  37. 37.
    Sewnath ME, Karsten TM, Prins MH et al (2002) A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 236(1):17–27PubMedCrossRefGoogle Scholar
  38. 38.
    Cameron JL (1990) Atlas of surgery, vol 1. BC Decker, PhiladelphiaGoogle Scholar
  39. 39.
    Herter FP, Cooperman AM, Ahlborn TN, Antinori C (1982) Surgical experience with pancreatic and periampullary cancer. Ann Surg 195:274–281PubMedCrossRefGoogle Scholar
  40. 40.
    Lerut JP, Gianello PR, Otte JB, Kestens PJ (1984) Pancreaticoduodenal resection: surgical experience and evluation of risk factors in 103 patients. Ann Surg 199:432–437PubMedCrossRefGoogle Scholar
  41. 41.
    Obertop H, Bruining HA, Schattenkerk ME et al (1982) Operative approach to cancer of the head of the pancreas and the periampullary region. Br J Surg 69:573–576PubMedCrossRefGoogle Scholar
  42. 42.
    Cameron JL, Pitt HA, Yeo CJ (1993) One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 217:430–438PubMedCrossRefGoogle Scholar
  43. 43.
    Lightner AM, Glasgow RE, Jordan TH et al (2004) Pancreatic resection in the elderly. J Am Coll Surg 198(5):697–706PubMedCrossRefGoogle Scholar
  44. 44.
    Hodul P, Tansey J, Golts E, Oh D, Pickleman J, Aranha GV (2001) Age is not a contraindication to pancreaticoduodenectomy. American Surgeon 67(3):270–275, discussion 275–276PubMedGoogle Scholar
  45. 45.
    Bathe OF, Caldera H, Hamilton KL et al (2001) Diminished benefit from resection of cancer of the head of the pancreas in patients of advanced age. J Surg Oncol 77(2):115–122PubMedCrossRefGoogle Scholar
  46. 46.
    Hannoun L, Christophe M, Ribeiro J et al (1993) A report of forty-four instances of pancreaticoduodenal resection in patients more than seventy years of age. Surg Gynecol Obstet 177(6):556–560PubMedGoogle Scholar
  47. 47.
    Fong Y, Blumgart LH, Fortner JG, Brennan MF (1995) Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 222(4):426–434, discussion 434–427PubMedGoogle Scholar
  48. 48.
    Vickers SM, Kerby JD, Smoot TM et al (1996) Economics of ­pancreatoduodenectomy in the elderly. Surgery 120(4):620–625, discussion 625–626PubMedCrossRefGoogle Scholar
  49. 49.
    Sohn TA, Yeo CJ, Cameron JL et al (1998) Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg 2(3):207–216PubMedCrossRefGoogle Scholar
  50. 50.
    DiCarlo V, Balzano G, Zerbi A, Villa E (1998) Pancreatic cancer resection in elderly patients. Br J Surg 85(5):607–610PubMedCrossRefGoogle Scholar
  51. 51.
    Bottger TC, Engelmann R, Junginger T (1999) Is age a risk factor for major pancreatic surgery? Hepatogastroenterology 46:2589PubMedGoogle Scholar
  52. 52.
    Al-Sharaf K, Andren-Sandberg A, Ihse I (1999) Subtotal pancreatectomy for cancer can be safe in the elderly. Eur J Surg 165(3):230–235PubMedCrossRefGoogle Scholar
  53. 53.
    Bathe OF, Levi D, Caldera H et al (2000) Radical resection of periampullary tumors in the elderly: evaluation of long-term results. World J Surg 24(3):353–358PubMedCrossRefGoogle Scholar
  54. 54.
    Brozzetti S, Mazzoni G, Miccini M et al (2006) Surgical treatment of pancreatic head carcinoma in elderly patients. Arch Surg 141(2):137–142PubMedCrossRefGoogle Scholar
  55. 55.
    Makary MA, Winter JM, Cameron JL et al (2006) Pancreaticoduo­denectomy in the very elderly. J Gastrointest Surg 10(3):347–356PubMedCrossRefGoogle Scholar
  56. 56.
    Scurtu R, Bachellier P, Oussoultzoglou E et al (2006) Outcome after pancreaticoduodenectomy for cancer in elderly patients. J Gastrointest Surg 10(6):813–822PubMedCrossRefGoogle Scholar
  57. 57.
    Casadei R, Zanini N, Morselli-Labate AM et al (2006) Prognostic factors in periampullary and pancreatic tumor resection in elderly patients. World J Surg 30(11):1992–2001PubMedCrossRefGoogle Scholar
  58. 58.
    Riall TS, Reddy DM, Nealon WH et al (2008) The effect of age on short-term outcomes after pancreatic resection: a population-based study. Ann Surg 248(3):459–467PubMedGoogle Scholar
  59. 59.
    Delcore R, Thomas JH, Hermreck AS (1991) Pancreaticoduo­denectomy for malignant pancreatic and periampullary neoplasms in elderly patients. Am J Surg 162:532–536PubMedCrossRefGoogle Scholar
  60. 60.
    Balcom JHT, Rattner DW, Warshaw AL, Chang Y, Fernandez-del Castillo C (2001) Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 136(4):391–398PubMedCrossRefGoogle Scholar
  61. 61.
    Schmidt CM, Powell ES, Yiannoutsos CT et al (2004) Pancrea­ticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 139(7):718–725, discussion 725–717PubMedCrossRefGoogle Scholar
  62. 62.
    Brennan MF, Kattan MW, Klimstra D et al (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240(2):293–298PubMedCrossRefGoogle Scholar
  63. 63.
    House MG, Fong Y, Arnaoutakis DJ et al (2008) Preoperative ­predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 12(2):270–278PubMedCrossRefGoogle Scholar
  64. 64.
    Sosa JA, Bowman HM, Gordon TA et al (1998) Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 228(3):429–438PubMedCrossRefGoogle Scholar
  65. 65.
    Bilimoria KY, Talamonti MS, Sener SF, Bilimoria MM, Stewart AK, Winchester DP, Ko CY, Bentrem DJ (2008) Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer. J Am Coll Surg 207(4):510–519PubMedCrossRefGoogle Scholar
  66. 66.
    Goodney PP, Stukel TA, Lucas FL et al (2003) Hospital volume, length of stay, and readmission rates in high-risk surgery. Ann Surg 238(2):161–167PubMedGoogle Scholar
  67. 67.
    Balzano G, Zerbi A, Capretti G, Rocchetti S, Capitanio V, Di Carlo V (2007) Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy. Br J Surg 95(3):357–362CrossRefGoogle Scholar
  68. 68.
    Allareddy V, Allareddy V, Konety BR (2007) Specificity of procedure volume and in-hospital mortality association. Ann Surg 246(1):135–139PubMedCrossRefGoogle Scholar
  69. 69.
    van Heek NT, Kuhlmann KFD, Scholten RJ, deCastro SMM, Busch ORC, van Gulik TM, Obertop H, Gouma DJ (2005) Hospital volume and mortality after pancreatic resection: A systematic review and an evaluation of intervention in the Netherlands. Ann Surg 242(6):781–790PubMedCrossRefGoogle Scholar
  70. 70.
    Birkmeyer JD, Siewers AE, Finlayson EV et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346(15):1128–1137PubMedCrossRefGoogle Scholar
  71. 71.
    Sledzianowski JF, Duffas JP, Muscari F, Suc B, Fourtanier F (2005) Risk factors for mortality and intra-abdominal morbidity after distal pancreatectomy. Surgery 137(2):180–185PubMedCrossRefGoogle Scholar
  72. 72.
    Lillemoe KD, Sauter PK, Pitt HA, Yeo CJ, Cameron JL (1993) Current status of surgical palliation of periampullary carcinoma. Surg Gynecol Obstet 176(1):1–10PubMedGoogle Scholar
  73. 73.
    Nuzzo G, Clemente G, Greco F, Ionta R, Cadeddu F (2004) Is the chronologic age a contra-indication for surgical palliation of unresectable periampullary neoplasms? J Surg Oncol 88(4):206–209PubMedCrossRefGoogle Scholar
  74. 74.
    Lillemoe KD, Cameron JL, Hardacre JM et al (1999) Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230(3):322–328, discussion 328–330PubMedCrossRefGoogle Scholar
  75. 75.
    Van Heek NT, deCastro SMM, van Eijck CH, van Geenen RCI, Hesselink EJ, Breslau PJ, Tran TCK, Kazemier G, Visser MRM, Busch ORC, Obertop H, Gouma DJ (2003) The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: A prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 238(6):894–905PubMedCrossRefGoogle Scholar
  76. 76.
    Navarra G, Musolino C, Venneri A, De Marco ML, Bartolotta M (2006) Palliative antecolic isoperistaltic gastrojejunostomy: a randomized controlled trial comparing open and laparoscopic approaches. Surg Endosc 20(12):1831–1834PubMedCrossRefGoogle Scholar
  77. 77.
    Kazanjian KK, Reber HA, Hines OJ (2004) Laparoscopic gastrojejunostomy for gastric outlet obstruction in pancreatic cancer. Am Surg 70(10):910–913PubMedGoogle Scholar
  78. 78.
    Jeurnink SM, Steyerberg EW, Hof G et al (2007) Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol 96(5):389–396PubMedCrossRefGoogle Scholar
  79. 79.
    Mercadante S, Arcuri E, Mercadante S, Arcuri E (2007) Pharmacological management of cancer pain in the elderly. Drugs Aging 24(9):761–776PubMedCrossRefGoogle Scholar
  80. 80.
    Wong GY, Schroeder DR, Carns PE et al (2004) Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 291(9):1092–1099PubMedCrossRefGoogle Scholar
  81. 81.
    Levy MJ, Wiersema MJ, Levy MJ, Wiersema MJ (2003) EUS-guided celiac plexus neurolysis and celiac plexus block. Gastrointest Endosc 57(7):923–930PubMedCrossRefGoogle Scholar
  82. 82.
    Yan BM, Myers RP, Yan BM, Myers RP (2007) Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol 102(2):430–438PubMedCrossRefGoogle Scholar
  83. 83.
    Lillemoe KD, Cameron JL, Kaufman HS, Yeo CJ, Pitt HA, Sauter PK (1993) Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 217(5):447–455, discussion 456–447PubMedCrossRefGoogle Scholar
  84. 84.
    Turrini O, Lillemoe KD, Schmidt CM. Preoperative score predicting survival of elderly patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma. (manuscript in preparation). Vol 2009.Google Scholar
  85. 85.
    Kalser M, Ellenberg SS (1985) Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120(8):899–903PubMedCrossRefGoogle Scholar
  86. 86.
    Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer. A randomised controlled trial. Lancet 358:1576–1585PubMedCrossRefGoogle Scholar
  87. 87.
    Palmer D, Stocken DD, Hewitt H, Markham CE, Hassan AB, Johnson PJ, Buckels JA, Bramhall SR (2007) A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin. Ann Surg Oncol 14(7):2088–2096PubMedCrossRefGoogle Scholar
  88. 88.
    Heinrich S, Pestalozzi BC, Schafer M, Weber A, Bauerfeind P, Knuth A, Clavien PA (2008) Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(15):2526–2531PubMedCrossRefGoogle Scholar
  89. 89.
    Morizane C, Okusaka T, Ito Y et al (2005) Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients. Oncology 68(4–6):432–437PubMedCrossRefGoogle Scholar
  90. 90.
    Marechal R, Demols A, Gay F et al (2008) Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer. Pancreas 36(3):e16–e21PubMedCrossRefGoogle Scholar
  91. 91.
    Krzyzanowska MK, Earle CC, Kuntz KM et al (2007) Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 67(1):211–218PubMedCrossRefGoogle Scholar
  92. 92.
    Millikan KW, Deziel DJ, Silverstein JC et al (1999) Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 65(7):618–623, discussion 623–614PubMedGoogle Scholar
  93. 93.
    Lim JE, Chien MW, Earle CC, Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237(1):74–85PubMedCrossRefGoogle Scholar
  94. 94.
    Eloubeidi M, Desmond R, Wilcox C, Wilson RJ et al (2006) Prognostic factors for survival in pancreatic cancer: a population study. Am J Surg 192(3):322–329PubMedCrossRefGoogle Scholar
  95. 95.
    Finlayson E, Fan Z, Birkmeyer JD, Finlayson E, Fan Z, Birkmeyer JD (2007) Outcomes in octogenarians undergoing high-risk cancer operation: a national study. J Am Coll Surg 205(6):729–734PubMedCrossRefGoogle Scholar
  96. 96.
    Birkmeyer JD, Sun Y, Wong SL et al (2007) Hospital volume and late survival after cancer surgery. Ann Surg 245(5):777–783PubMedCrossRefGoogle Scholar
  97. 97.
    Bilimoria KY, Bentrem DJ, Ko CY et al (2007) National failure to operate on early stage pancreatic cancer. Ann Surg 246(2):173–180PubMedCrossRefGoogle Scholar
  98. 98.
    Baxter NN, Whitson BA, Tuttle TM, Baxter NN, Whitson BA, Tuttle TM (2007) Trends in the treatment and outcome of pancreatic cancer in the United States. Ann Surg Oncol 14(4):1320–1326PubMedCrossRefGoogle Scholar
  99. 99.
    Gawron AJ, Gapstur SM, Fought AJ et al (2008) Sociodemographic and tumor characteristics associated with pancreatic cancer surgery in the United States. J Surg Oncol 97(7):578–582PubMedCrossRefGoogle Scholar
  100. 100.
    O'Connell JB, Maggard MA, Ko CY, O'Connell JB, Maggard MA, Ko CY (2004) Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol 11(11):962–969PubMedCrossRefGoogle Scholar
  101. 101.
    Goh BK, Tan YM, Thng CH et al (2008) How useful are clinical, biochemical, and cross-sectional imaging features in predicting potentially malignant or malignant cystic lesions of the pancreas? Results from a single institution experience with 220 surgically treated patients. J Am Coll Surg 206(1):17–27PubMedCrossRefGoogle Scholar
  102. 102.
    Khalid A, Brugge W, Khalid A, Brugge W (2007) ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol 102(10):2339–2349PubMedCrossRefGoogle Scholar
  103. 103.
    Shami VM, Sundaram V, Stelow EB et al (2007) The level of carcinoembryonic antigen and the presence of mucin as predictors of cystic pancreatic mucinous neoplasia. Pancreas 34(4):466–469PubMedCrossRefGoogle Scholar
  104. 104.
    Schmidt CM, Yip-Schneider MT, Ralstin MC et al (2008) PGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia. J Gastrointest Surg 12(2):243–249PubMedCrossRefGoogle Scholar
  105. 105.
    Brugge WR (2004) Evaluation of pancreatic cystic lesions with EUS. Gastrointest Endosc 59(6):698–707PubMedCrossRefGoogle Scholar
  106. 106.
    Traverso WL, Kozarek RA (2008) Diagnosis and natural history of intraductal papillary mucinous neoplasms. In: Beger HG, Warshaw A, Buchler M, Kozarek R, Lerch M, Neoptolemos J, Shiratori K, Whitcomb D (eds) The pancreas: an integrated textbook of basic science, medicine, and surgery. Blackwell, OxfordGoogle Scholar
  107. 107.
    Goh BK, Tan YM, Cheow PC et al (2006) Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years. Am J Surg 192(2):148–154PubMedCrossRefGoogle Scholar
  108. 108.
    Rodriguez JR, Madanat MG, Healy BC et al (2007) Distal pancreatectomy with splenic preservation revisited. Surgery 141(5):619–625PubMedCrossRefGoogle Scholar
  109. 109.
    Kooby DA, Gillespie T, Bentram D, Nakeeb A, Schmidt CM, Merchant NB, Parikh AA, Martin RCG, Scoggins CR, Ahmad S, Kim HJ, Park J, Johnston F, Strouch MJ, Menze A, Rymer J, McClaine R, Strasberg SM, Talamonti MS, Staley SA, McMasters KM, Lowy AM, Byrd-Sellers J, Wood WC, Hawkins WG (2008) Left-sided pancreatectomy: A multicenter conmparison of laparoscopic and open approaches. Ann Surg 248(3):438–446PubMedGoogle Scholar
  110. 110.
    Madura JA, Yum MN, Lehman GA et al (2004) Mucin secreting cystic lesions of the pancreas: treatment by enucleation. Am Surg 70(2):106–112PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of SurgeryIndiana University HospitalIndianapolisUSA

Personalised recommendations